Literature for peptidase M12.225: ADAMTS5 peptidase

(Topics flags: A Assay, S Structure, T Target, P Specificity, K Knockout, I Inhibitor, V Review. To select only the references relevant to a single topic, click the link above. See explanation.)

2024
1. Chen,Z., Du,F., Zhang,R., Wu,Q., Lu,Z., Zhang,R.L. and Wang,Q.
   ADAMTS5 Promotes Permeability of the Blood-Brain Barrier during Treponema pallidum Subspecies pallidum Invading the Central Nervous System
   ACS Infect Dis10, 1222-1231. PubMed  Europe PubMed DOI
2023
2. Liu,Y., Yao,Y., Zhang,Y., Yan,C., Yang,M., Wang,Z., Li,W., Li,F., Wang,W., Yang,Y., Li,X. and Tang,Z.
   MicroRNA-200c-5p Regulates Migration and Differentiation of Myoblasts via Targeting Adamts5 in Skeletal Muscle Regeneration and Myogenesis
   Int J Mol Sci24, PubMed  Europe PubMed DOI
2022
3. He,S., Li,J., Ma,D., Liu,Z. and Lv,N.
   MicroRNA-148a targets ADAMTS5 to inhibit proliferation of endometriosis cells
   Pak J Pharm Sci35, 335-341. PubMed  Europe PubMed
4. Porto,C., Rogers-DeCotes,A., Schafer,E. and Kern,B.
   The adaptive response of the mandibular condyle to increased load is disrupted by c deficiency
   Connect Tissue Res1-12. PubMed  Europe PubMed DOI
5. Yu,Y., Liu,M., Choi,V.N.T., Cheung,Y.W. and Tanner,J.A.
   Selection and characterization of DNA aptamers inhibiting a druggable target of osteoarthritis, ADAMTS-5
   Biochimie201, 168-176. PubMed  Europe PubMed DOI
2021
6. Martin,D.R., Santamaria,S., Koch,C.D., Ahnstrom,J. and Apte,S.S.
   Identification of novel ADAMTS1, ADAMTS4 and ADAMTS5 cleavage sites in versican using a label-free quantitative proteomics approach
   J Proteomics249, 104358-104358. PubMed  Europe PubMed DOI
7. Santamaria,S., Cuffaro,D., Nuti,E., Ciccone,L., Tuccinardi,T., Liva,F., D'Andrea,F., de Groot,R., Rossello,A. and Ahnstrom,J.
   Exosite inhibition of ADAMTS-5 by a glycoconjugated arylsulfonamide
   Sci Rep11, 949-949. PubMed  Europe PubMed DOI  I
2020
8. Fowkes,M.M. and Lim,N.H.
   Purification and activity determination of ADAMTS-4 and ADAMTS-5 and their domain deleted mutants
   Methods Mol Biol2043, 75-91. PubMed  Europe PubMed DOI  V
9. Hong,C.C., Tang,A.T., Detter,M.R., Choi,J.P., Wang,R., Yang,X., Guerrero,A.A., Wittig,C.F., Hobson,N., Girard,R., Lightle,R., Moore,T., Shenkar,R., Polster,S.P., Goddard,L.M., Ren,A.A., Leu,N.A., Sterling,S., Yang,J., Li,L., Chen,M., Mericko-Ishizuka,P., Dow,L.E., Watanabe,H., Schwaninger,M., Min,W., Marchuk,D.A., Zheng,X., Awad,I.A. and Kahn,M.L.
   Cerebral cavernous malformations are driven by ADAMTS5 proteolysis of versican
   J Exp Med217, PubMed  Europe PubMed DOI
2019
10. Dupuis,L.E., Nelson,E.L., Hozik,B., Porto,S.C., Rogers-DeCotes,A., Fosang,A. and Kern,C.B.
    Adamts5(-/-) mice exhibit altered aggrecan proteolytic profiles that correlate with ascending aortic anomalies
    Arterioscler Thromb Vasc Biol39, 2067-2081. PubMed  Europe PubMed DOI  K
11. Malemud,C.J.
    Inhibition of MMPs and ADAM/ADAMTS
    Biochem Pharmacol165, 33-40. PubMed  Europe PubMed DOI  I
12. Santamaria,S., Yamamoto,K., Teraz-Orosz,A., Koch,C., Apte,S.S., de Groot,R., Lane,D.A. and Ahnstrom,J.
    Exosites in hypervariable loops of ADAMTS spacer domains control substrate recognition and proteolysis
    Sci Rep9, 10914-10914. PubMed  Europe PubMed DOI  P
13. Scavenius,C., Poulsen,E.C., Thogersen,I.B., Roebuck,M., Frostick,S., Bou-Gharios,G., Yamamoto,K., Deleuran,B. and Enghild,J.J.
    Matrix-degrading protease ADAMTS-5 cleaves inter-alpha-inhibitor and releases active heavy chain 2 in synovial fluids from arthritic patients
    J Biol Chem294, 15495-15504. PubMed  Europe PubMed DOI
2018
14. Fava,M., Barallobre-Barreiro,J., Mayr,U., Lu,R., Didangelos,A., Baig,F., Lynch,M., Catibog,N., Joshi,A., Barwari,T., Yin,X., Jahangiri,M. and Mayr,M.
    Role of ADAMTS-5 in aortic dilatation and extracellular matrix remodeling
    Arterioscler Thromb Vasc Biol38, 1537-1548. PubMed  Europe PubMed DOI
2016
15. Apte,S.S.
    Anti-ADAMTS5 monoclonal antibodies: implications for aggrecanase inhibition in osteoarthritis
    Biochem J473, e1-e4. PubMed  Europe PubMed DOI
16. Biniossek,M.L., Niemer,M., Maksimchuk,K., Mayer,B., Fuchs,J., Huesgen,P.F., McCafferty,D.G., Turk,B., Fritz,G., Mayer,J., Haecker,G., Mach,L. and Schilling,O.
    Identification of protease specificity by combining proteome-derived peptide libraries and quantitative proteomics
    Mol Cell Proteomics15, 2515-2524. PubMed  Europe PubMed DOI  P
17. Kosasih,H.J., Last,K., Rogerson,F.M., Golub,S.B., Gauci,S.J., Russo,V.C., Stanton,H., Wilson,R., Lamande,S.R., Holden,P. and Fosang,A.J.
    A disintegrin and metalloproteinase with thrombospondin motifs-5 (ADAMTS-5) forms catalytically active oligomers
    J Biol Chem291, 3197-3208. PubMed  Europe PubMed DOI
2014
18. Demircan,K., Topcu,V., Takigawa,T., Akyol,S., Yonezawa,T., Ozturk,G., Ugurcu,V., Hasgul,R., Yigitoglu,M.R., Akyol,O., McCulloch,D.R. and Hirohata,S.
    ADAMTS4 and ADAMTS5 knockout mice are protected from versican but not aggrecan or brevican proteolysis during spinal cord injury
    Biomed Res Int2014, 693746-693746. PubMed  Europe PubMed DOI  K
19. Durham,T.B., Klimkowski,V.J., Rito,C.J., Marimuthu,J., Toth,J.L., Liu,C., Durbin,J.D., Stout,S.L., Adams,L., Swearingen,C., Lin,C., Chambers,M.G., Thirunavukkarasu,K. and Wiley,M.R.
    Identification of potent and selective hydantoin inhibitors of aggrecanase-1 and aggrecanase-2 that are efficacious in both chemical and surgical models of osteoarthritis
    J Med Chem57, 10476-10485. PubMed  Europe PubMed DOI  I
20. Foulcer,S.J., Nelson,C.M., Quintero,M.V., Kuberan,B., Larkin,J., Dours-Zimmermann,M.T., Zimmermann,D.R. and Apte,S.S.
    Determinants of versican-V1 proteoglycan processing by the metalloproteinase ADAMTS5
    J Biol Chem289, 27859-27873. PubMed  Europe PubMed DOI  P
21. Wang,Z., Luo,J., Iwamoto,S. and Chen,Q.
    Matrilin-2 is proteolytically cleaved by ADAMTS-4 and ADAMTS-5
    Molecules19, 8472-8487. PubMed  Europe PubMed DOI
2013
22. Miller,R.E., Lu,Y., Tortorella,M.D. and Malfait,A.M.
    Genetically engineered mouse models reveal the importance of proteases as osteoarthritis drug targets
    Curr Rheumatol Rep15, 350-350. PubMed  Europe PubMed DOI  K
23. Stupka,N., Kintakas,C., White,J.D., Fraser,F.W., Hanciu,M., Aramaki-Hattori,N., Martin,S., Coles,C., Collier,F., Ward,A.C., Apte,S.S. and McCulloch,D.R.
    Versican processing by a disintegrin-like and metalloproteinase domain with thrombospondin-1 repeats proteinases-5 and -15 facilitates myoblast fusion
    J Biol Chem288, 1907-1917. PubMed  Europe PubMed DOI
24. Yamamoto,K., Troeberg,L., Scilabra,S.D., Pelosi,M., Murphy,C.L., Strickland,D.K. and Nagase,H.
    LRP-1-mediated endocytosis regulates extracellular activity of ADAMTS-5 in articular cartilage
    FASEB J27, 511-521. PubMed  Europe PubMed DOI
2012
25. Bondeson,J., Wainwright,S., Caterson,B. and Hughes,C.
    ADAMTS5
    [ISSN:978-0-12-407744-7]3, 1174-1180. DOI
26. Gao,W., Zhu,J., Westfield,L.A., Tuley,E.A., Anderson,P.J. and Sadler,J.E.
    Rearranging exosites in noncatalytic domains can redirect the substrate specificity of ADAMTS proteases
    J Biol Chem287, 26944-26952. PubMed  Europe PubMed DOI
27. Troeberg,L., Mulloy,B., Ghosh,P., Lee,M.H., Murphy,G. and Nagase,H.
    Pentosan polysulfate increases affinity between ADAMTS-5 and TIMP-3 through formation of an electrostatically driven trimolecular complex
    Biochem J443, 307-315. PubMed  Europe PubMed DOI
28. Troeberg,L. and Nagase,H.
    Proteases involved in cartilage matrix degradation in osteoarthritis
    Biochim Biophys Acta1824, 133-145. PubMed  Europe PubMed DOI  V
2011
29. De Savi,C., Pape,A., Sawyer,Y., Milne,D., Davies,C., Cumming,J.G., Ting,A., Lamont,S., Smith,P.D., Tart,J., Page,K. and Moore,P.
    Orally active achiral N-hydroxyformamide inhibitors of ADAM-TS4 (aggrecanase-1) and ADAM-TS5 (aggrecanase-2) for the treatment of osteoarthritis
    Bioorg Med Chem Lett21, 3301-3306. PubMed  Europe PubMed DOI  I
30. Hattori,N., Carrino,D.A., Lauer,M.E., Vasanji,A., Wylie,J.D., Nelson,C.M. and Apte,S.S.
    Pericellular versican regulates the fibroblast-myofibroblast transition: a role for ADAMTS5 protease-mediated proteolysis
    J Biol Chem286, 34298-34310. PubMed  Europe PubMed DOI  K
31. Stanton,H., Melrose,J., Little,C.B. and Fosang,A.J.
    Proteoglycan degradation by the ADAMTS family of proteinases
    Biochim Biophys Acta Mol Basis Dis1812, 1616-1629. PubMed  Europe PubMed DOI  P
2010
32. Fosang,A.J. and Rogerson,F.M.
    Identifying the human aggrecanase
    Osteoarthritis Cartilage18, 1109-1116. PubMed  Europe PubMed DOI
33. Lim,N.H., Kashiwagi,M., Visse,R., Jones,J., Enghild,J.J., Brew,K. and Nagase,H.
    Reactive-site mutants of N-TIMP-3 that selectively inhibit ADAMTS-4 and ADAMTS-5: biological and structural implications
    Biochem J431, 113-122. PubMed  Europe PubMed DOI
34. Lin,E.A. and Liu,C.J.
    The role of ADAMTSs in arthritis
    Protein Cell1, 33-47. PubMed  Europe PubMed DOI
35. McCulloch,D.R., Wylie,J.D., Longpre,J.M., Leduc,R. and Apte,S.S.
    10mM glucosamine prevents activation of proADAMTS5 (aggrecanase-2) in transfected cells by interference with post-translational modification of furin
    Osteoarthritis Cartilage18, 455-463. PubMed  Europe PubMed DOI
2009
36. Longpre,J.M., McCulloch,D.R., Koo,B.H., Alexander,J.P., Apte,S.S. and Leduc,R.
    Characterization of proADAMTS5 processing by proprotein convertases
    Int J Biochem Cell Biol41, 1116-1126. PubMed  Europe PubMed DOI
37. McCulloch,D.R., Nelson,C.M., Dixon,L.J., Silver,D.L., Wylie,J.D., Lindner,V., Sasaki,T., Cooley,M.A., Argraves,W.S. and Apte,S.S.
    ADAMTS metalloproteases generate active versican fragments that regulate interdigital web regression
    Dev Cell17, 687-698. PubMed  Europe PubMed DOI
38. McCulloch,D.R., Le Goff,C., Bhatt,S., Dixon,L.J., Sandy,J.D. and Apte,S.S.
    Adamts5, the gene encoding a proteoglycan-degrading metalloprotease, is expressed by specific cell lineages during mouse embryonic development and in adult tissues
    Gene Expr Patterns9, 314-323. PubMed  Europe PubMed DOI
39. Tortorella,M.D., Tomasselli,A.G., Mathis,K.J., Schnute,M.E., Woodard,S.S., Munie,G., Williams,J.M., Caspers,N., Wittwer,A.J., Malfait,A.M. and Shieh,H.S.
    Structural and inhibition analysis reveals the mechanism of selectivity of a series of aggrecanase inhibitors
    J Biol Chem284, 24185-24191. PubMed  Europe PubMed DOI  I
40. Tortorella,M.D., Malfait,F., Barve,R.A., Shieh,H.S. and Malfait,A.M.
    A review of the ADAMTS family, pharmaceutical targets of the future
    Curr Pharm Des15, 2359-2374. PubMed  Europe PubMed DOI  V  T
41. Troeberg,L., Fushimi,K., Scilabra,S.D., Nakamura,H., Dive,V., Thogersen,I.B., Enghild,J.J. and Nagase,H.
    The C-terminal domains of ADAMTS-4 and ADAMTS-5 promote association with N-TIMP-3
    Matrix Biol28, 463-469. PubMed  Europe PubMed DOI
2008
42. Bondeson,J., Wainwright,S., Hughes,C. and Caterson,B.
    The regulation of the ADAMTS4 and ADAMTS5 aggrecanases in osteoarthritis: a review
    Clin Exp Rheumatol26, 139-145. PubMed  Europe PubMed
43. Fosang,A.J. and Little,C.B.
    Drug insight: aggrecanases as therapeutic targets for osteoarthritis
    Nat Clin Pract Rheumatol4, 420-427. PubMed  Europe PubMed DOI  T
44. Fosang,A.J., Rogerson,F.M., East,C.J. and Stanton,H.
    ADAMTS-5: the story so far
    Eur Cell Mater15, 11-26. PubMed  Europe PubMed  V
45. Fushimi,K., Troeberg,L., Nakamura,H., Lim,N.H. and Nagase,H.
    Functional differences of the catalytic and non-catalytic domains in human ADAMTS-4 and ADAMTS-5 in aggrecanolytic activity
    J Biol Chem283, 6706-6716. PubMed  Europe PubMed DOI
46. Malfait,A.M., Arner,E.C., Song,R.H., Alston,J.T., Markosyan,S., Staten,N., Yang,Z., Griggs,D.W. and Tortorella,M.D.
    Proprotein convertase activation of aggrecanases in cartilage in situ
    Arch Biochem Biophys478, 43-51. PubMed  Europe PubMed DOI  T
47. Mosyak,L., Georgiadis,K., Shane,T., Svenson,K., Hebert,T., McDonagh,T., Mackie,S., Olland,S., Lin,L., Zhong,X., Kriz,R., Reifenberg,E.L., Collins-Racie,L.A., Corcoran,C., Freeman,B., Zollner,R., Marvell,T., Vera,M., Sum,P.E., LaVallie,E.R., Stahl,M. and Somers,W.
    Crystal structures of the two major aggrecan degrading enzymes, ADAMTS4 and ADAMTS5
    Protein Sci17, 16-21. PubMed  Europe PubMed DOI  S
48. Shieh,H.S., Mathis,K.J., Williams,J.M., Hills,R.L., Wiese,J.F., Benson,T.E., Kiefer,J.R., Marino,M.H., Carroll,J.N., Leone,J.W., Malfait,A.M., Arner,E.C., Tortorella,M.D. and Tomasselli,A.
    High resolution crystal structure of the catalytic domain of ADAMTS-5 (aggrecanase-2)
    J Biol Chem283, 1501-1507. PubMed  Europe PubMed DOI  S
49. Troeberg,L., Fushimi,K., Khokha,R., Emonard,H., Ghosh,P. and Nagase,H.
    Calcium pentosan polysulfate is a multifaceted exosite inhibitor of aggrecanases
    FASEB J22, 3515-3524. PubMed  Europe PubMed DOI
2007
50. East,C.J., Stanton,H., Golub,S.B., Rogerson,F.M. and Fosang,A.J.
    ADAMTS-5 deficiency does not block aggrecanolysis at preferred cleavage sites in the chondroitin sulfate-rich region of aggrecan
    J Biol Chem282, 8632-8640. PubMed  Europe PubMed DOI  K
51. Gendron,C., Kashiwagi,M., Lim,N.H., Enghild,J.J., Thogersen,I.B., Hughes,C., Caterson,B. and Nagase,H.
    Proteolytic activities of human ADAMTS-5: comparative studies with ADAMTS-4
    J Biol Chem282, 18294-18306. PubMed  Europe PubMed DOI
52. Ilic,M.Z., East,C.J., Rogerson,F.M., Fosang,A.J. and Handley,C.J.
    Distinguishing aggrecan loss from aggrecan proteolysis in ADAMTS-4 and ADAMTS-5 single and double deficient mice
    J Biol Chem282, 37420-37428. PubMed  Europe PubMed DOI  K
53. Powell,A.J., Little,C.B. and Hughes,C.E.
    Low molecular weight isoforms of the aggrecanases are responsible for the cytokine-induced proteolysis of aggrecan in a porcine chondrocyte culture system
    Arthritis Rheum56, 3010-3019. PubMed  Europe PubMed DOI
54. Song,R.H., Tortorella,M.D., Malfait,A.M., Alston,J.T., Yang,Z., Arner,E.C. and Griggs,D.W.
    Aggrecan degradation in human articular cartilage explants is mediated by both ADAMTS-4 and ADAMTS-5
    Arthritis Rheum56, 575-585. PubMed  Europe PubMed DOI
55. Thirunavukkarasu,K., Pei,Y. and Wei,T.
    Characterization of the human ADAMTS-5 (aggrecanase-2) gene promoter
    Mol Biol Rep34, 225-231. PubMed  Europe PubMed DOI
2006
56. Melching,L.I., Fisher,W.D., Lee,E.R., Mort,J.S. and Roughley,P.J.
    The cleavage of biglycan by aggrecanases
    Osteoarthritis Cartilage14, 1147-1154. PubMed  Europe PubMed DOI
2005
57. [YEAR:31-3-2005]Glasson,S.S., Askew,R., Sheppard,B., Carito,B., Blanchet,T., Ma,H.L., Flannery,C.R., Peluso,D., Kanki,K., Yang,Z., Majumdar,M.K. and Morris,E.A.
    Deletion of active ADAMTS5 prevents cartilage degradation in a murine model of osteoarthritis
    Nature434, 644-648. PubMed  Europe PubMed DOI  K
58. Nakada,M., Miyamori,H., Kita,D., Takahashi,T., Yamashita,J., Sato,H., Miura,R., Yamaguchi,Y. and Okada,Y.
    Human glioblastomas overexpress ADAMTS-5 that degrades brevican
    Acta Neuropathol110, 239-246. PubMed  Europe PubMed DOI
59. [YEAR:19-1-2005]Richards,J.S., Hernandez-Gonzalez,I., Gonzalez-Robayna,I., Teuling,E., Lo,Y., Boerboom,D., Falender,A.E., Doyle,K.H., LeBaron,R.G., Thompson,V. and Sandy,J.D.
    Regulated expression of ADAMTS family members in follicles and cumulus oocyte complexes: evidence for specific and redundant patterns during ovulation
    Biol Reprod72, 1241-1255. PubMed  Europe PubMed DOI
60. [YEAR:31-3-2005]Stanton,H., Rogerson,F.M., East,C.J., Golub,S.B., Lawlor,K.E., Meeker,C.T., Little,C.B., Last,K., Farmer,P.J., Campbell,I.K., Fourie,A.M. and Fosang,A.J.
    ADAMTS5 is the major aggrecanase in mouse cartilage in vivo and in vitro
    Nature434, 648-652. PubMed  Europe PubMed DOI
2004
61. Arai,M., Anderson,D., Kurdi,Y., Annis-Freeman,B., Shields,K., Collins-Racie,L.A., Corcoran,C., DiBlasio-Smith,E., Pittman,D.D., Dorner,A.J., Morris,E. and LaVallie,E.R.
    Effect of adenovirus-mediated overexpression of bovine ADAMTS-4 and human ADAMTS-5 in primary bovine articular chondrocyte pellet culture system
    Osteoarthritis Cartilage12, 599-613. PubMed  Europe PubMed DOI
62. Hughes,C.E., Caterson,B., Little,C.B. and Wainwright,S.W.
    Aggrecanases 1 and 2
    [ISSN:0-12-079610-4]2, 740-746.  V
63. [YEAR:7-1-2004]Tortorella,M.D., Arner,E.C., Hills,R., Easton,A., Korte-Sarfaty,J., Fok,K., Wittwer,A.J., Liu,R.Q. and Malfait,A.M.
    Alpha2-macroglobulin is a novel substrate for ADAMTS-4 and ADAMTS-5 and represents an endogenous inhibitor of these enzymes
    J Biol Chem279, 17554-17561. PubMed  Europe PubMed DOI
2003
64. Makihira,S., Yan,W., Murakami,H., Furukawa,M., Kawai,T., Nikawa,H., Yoshida,E., Hamada,T., Okada,Y. and Kato,Y.
    Thyroid hormone enhances aggrecanase-2/ADAM-TS5 expression and proteoglycan degradation in growth plate cartilage
    Endocrinology144, 2480-2488. PubMed  Europe PubMed DOI
65. [YEAR:15-3-2003]Miller,J.A., Liu,R.Q., Davis,G.L., Pratta,M.A., Trzaskos,J.M. and Copeland,R.A.
    A microplate assay specific for the enzyme aggrecanase
    Anal Biochem314, 260-265. PubMed  Europe PubMed DOI  A
2002
66. Arner,E.C.
    Aggrecanase-mediated cartilage degradation
    Curr Opin Pharmacol2, 322-329. PubMed  Europe PubMed DOI
67. [YEAR:21-6-2002]Malfait,A.M., Liu,R.Q., Ijiri,K., Komiya,S. and Tortorella,M.D.
    Inhibition of ADAM-TS4 and ADAM-TS5 prevents aggrecan degradation in osteoarthritic cartilage
    J Biol Chem277, 22201-22208. PubMed  Europe PubMed DOI
68. Tortorella,M.D., Liu,R.Q., Burn,T., Newton,R.C. and Arner,E.
    Characterization of human aggrecanase 2 (ADAM-TS5): substrate specificity studies and comparison with aggrecanase 1 (ADAM-TS4)
    Matrix Biol21, 499-511. PubMed  Europe PubMed DOI
69. [YEAR:1-2-2002]Yamanishi,Y., Boyle,D.L., Clark,M., Maki,R.A., Tortorella,M.D., Arner,E.C. and Firestein,G.S.
    Expression and regulation of aggrecanase in arthritis: the role of TGF-beta
    J Immunol168, 1405-1412. PubMed  Europe PubMed
2001
70. Tortorella,M.D., Malfait,A.M., Deccico,C. and Arner,E.
    The role of ADAM-TS4 (aggrecanase-1) and ADAM-TS5 (aggrecanase-2) in a model of cartilage degradation
    Osteoarthritis Cartilage9, 539-552. PubMed  Europe PubMed DOI
71. Vankemmelbeke,M.N., Holen,I., Wilson,A.G., Ilic,M.Z., Handley,C.J., Kelner,G.S., Clark,M., Liu,C., Maki,R.A., Burnett,D. and Buttle,D.J.
    Expression and activity of ADAMTS-5 in synovium
    Eur J Biochem268, 1259-1268. PubMed  Europe PubMed DOI
2000
72. [YEAR:13-8-1999]Abbaszade,I., Liu,R.Q., Yang,F., Rosenfeld,S.A., Ross,O.H., Link,J.R., Ellis,D.M., Tortorella,M.D., Pratta,M.A., Hollis,J.M., Wynn,R., Duke,J.L., George,H.J., Hillman,M.C., Jr., Murphy,K., Wiswall,B.H., Copeland,R.A., Decicco,C.P., Bruckner,R., Nagase,H., Itoh,Y., Newton,R.C., Magolda,R.L., Trzaskos,J.M. and Burn,T.C.
    Cloning and characterization of ADAMTS11, an aggrecanase from the ADAMTS family
    J Biol Chem274, 23443-23450. PubMed  Europe PubMed DOI
1999
73. [YEAR:5-7-1999]Flannery,C.R., Little,C.B., Hughes,C.E. and Caterson,B.
    Expression of ADAMTS homologues in articular cartilage
    Biochem Biophys Res Commun260, 318-322. PubMed  Europe PubMed DOI
74. [YEAR:3-9-1999]Hurskainen,T.L., Hirohata,S., Seldin,M.F. and Apte,S.S.
    ADAM-TS5, ADAM-TS6, and ADAM-TS7, novel members of a new family of zinc metalloproteases. General features and genomic distribution of the ADAM-TS family
    J Biol Chem274, 25555-25563. PubMed  Europe PubMed DOI